Literature DB >> 8180914

The impact of fatigue on patients with multiple sclerosis.

J D Fisk1, A Pontefract, P G Ritvo, C J Archibald, T J Murray.   

Abstract

Although fatigue is recognized as a symptom of MS, there have been insufficient methods for evaluating this symptom. We administered the Fatigue Impact Scale to 85 MS patients and 20 hypertensive patients. Neurologic impairment, mental health, and general health status were also assessed. MS patients reported significantly higher fatigue impact than hypertensive patients. Most MS patients reported fatigue as either their worst (14%), or one of their worst (55%) symptoms. Disease classification and neurologic impairment had little bearing on Fatigue Impact Scale scores in the MS sample. The best predictive models for mental health and general health status in the MS sample both included the Fatigue Impact Scale as a significant factor. This study demonstrates that: 1) fatigue is a very prevalent and severe problem in MS, 2) fatigue impact cannot be predicted by clinical measures of neurologic impairment, 3) fatigue has a significant effect on the mental health and general health status of MS patients.

Entities:  

Mesh:

Year:  1994        PMID: 8180914

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  203 in total

Review 1.  Fatigue in multiple sclerosis: definition, pathophysiology and treatment.

Authors:  Lauren B Krupp
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  Recommendations for physical activity in patients with multiple sclerosis.

Authors:  J H Petajan; A T White
Journal:  Sports Med       Date:  1999-03       Impact factor: 11.136

Review 3.  Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment.

Authors:  Tiffany J Braley; Ronald D Chervin
Journal:  Sleep       Date:  2010-08       Impact factor: 5.849

4.  Complementary and alternative medicine for the treatment of multiple sclerosis.

Authors:  Vijayshree Yadav; Lynne Shinto; Dennis Bourdette
Journal:  Expert Rev Clin Immunol       Date:  2010-05       Impact factor: 4.473

5.  A novel approach to estimate the minimally important difference for the Fatigue Impact Scale in multiple sclerosis patients.

Authors:  Regina Rendas-Baum; Min Yang; Francoise Cattelin; Gene V Wallenstein; John D Fisk
Journal:  Qual Life Res       Date:  2010-07-10       Impact factor: 4.147

6.  Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study.

Authors:  Peter J Jongen; Dirk Lehnick; Evert Sanders; Pierette Seeldrayers; Sten Fredrikson; Magnus Andersson; Joachim Speck
Journal:  Health Qual Life Outcomes       Date:  2010-11-15       Impact factor: 3.186

7.  Assessing the gap between current movement ability and preferred movement ability as a measure of disability.

Authors:  Diane D Allen; Joanne M Wagner
Journal:  Phys Ther       Date:  2011-10-14

Review 8.  Carnitine for fatigue in multiple sclerosis.

Authors:  Aaron M Tejani; Michael Wasdell; Rae Spiwak; Greg Rowell; Shabita Nathwani
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

9.  Thomas John (Jock) Murray, OC, MD, FRCP(C), MACP, LLD(HON), DSc(Hon), FRCP(Lon): a conversation with the editor. Interview by William Clifford Roberts.

Authors:  Thomas John Murray
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-10

10.  Use of cognitive aids and other assistive technology by individuals with multiple sclerosis.

Authors:  Kurt L Johnson; Alyssa M Bamer; Kathryn M Yorkston; Dagmar Amtmann
Journal:  Disabil Rehabil Assist Technol       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.